REMSleep Holdings, Inc. (RMSL) Stock Price & Analysis
REMSleep Holdings, Inc. (RMSL) — price $0.0012 (+9.09%), as of the Nov 20, 2026 trading session; market cap $2.09M.
Educational signal · not a buy or sell recommendation · How to read this
REMSleep Holdings, Inc. · RMSL
REMSleep Holdings, Inc. is a global enterprise focused on providing solutions for individuals with sleep apnea, primarily through its DeltaWave CPAP interface device. The company serves a diverse client base, including home healthcare providers, sleep clinics, and medical associations, from its Tampa, Florida headquarters.
Price as of Nov 20, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.0012 | |
| Change on the day | +9.09% | |
| Market capitalisation | $2.09M | — |
| Shares traded on the day | 175.4K |
Price & events
Other perspectives
Council score for REMSleep Holdings (RMSL): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 8, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Apr 29, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Apr 29, 2026, the Munger lens read the price at that time as overvalued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is REMSleep Holdings (RMSL), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. REMSleep Holdings, Inc. (RMSL) is the company analyzed here. It employs 2 people. In Q2 FY2026 it reported revenue of $14,738 and net income of -$103,486. The market values it at $2.09M.
What do the latest results show for REMSleep Holdings (RMSL)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $14,738.
Quarterly income statement — 3 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $14,738 | -$103,486 | -$0.0001 (diluted) |
| Q4 FY2025 | $4,443 | -$3020.30B | -$1926.47 (diluted) |
| Q3 FY2025 | $7,454 | -$2M | -$0.0015 (diluted) |
What are the financial strengths and risks for REMSleep Holdings (RMSL)?
Short answer · as of
The distress and quality screens read Piotroski F 2. Trailing ratios: current ratio 0.20.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held RMSL in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported RMSL in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Investor Questions: RMSL Stock
These answers are editorial: 1 of these 1 answer is drawn from the RMSL research dossier (written Jun 14, 2026 by gemini-2.5-flash). Figures in this section are not part of the source register.
What is REMSleep Holdings, Inc.'s primary product and its market focus?
REMSleep Holdings, Inc. is primarily focused on developing and providing solutions for individuals suffering from sleep apnea. Its flagship product is the DeltaWave CPAP interface device, specifically engineered to assist in the treatment of this condition. The company's market focus is global, targeting a broad spectrum of clients within the healthcare ecosystem.
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 11 figures on this page — 8 from Financial Modeling Prep (FMP) and 3 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com